The Royce Small-Cap Growth Fund is a domestic stock fund with a long-term capital growth objective. Its September 30, 2026 fact sheet describes a portfolio focused primarily on small-cap companies the adviser believes have above-average growth prospects. For investors reviewing the fund, the key considerations include its growth-oriented strategy, fluctuating returns, sector exposures, expenses, and the risks associated with smaller companies.
Royce Small-Cap Growth Fund strategy
The fund normally invests at least 80% of its net assets in equity securities of small-cap companies. Although it generally focuses on U.S. companies, it may invest up to 25% of net assets, measured at the time of investment, in equity securities of companies headquartered outside the United States.
This approach combines exposure to smaller businesses with a growth investment style. The adviser selects companies it considers to have above-average growth prospects; however, the fact sheet does not suggest that those prospects are assured. Growth securities can be sensitive to changes in market expectations and may lose value if investors believe expected earnings will not be achieved.
Performance compared with the Russell 2000 Index
The fund’s benchmark is the Russell 2000 Index. For periods ended September 30, 2026, the fund reported a 29.94% return over one year, compared with 16.20% for the benchmark. Its reported three-year average annual return was 26.48%, versus 17.72% for the index. Over five years, the fund returned an average of 6.17% annually, compared with 6.34% for the benchmark. Over ten years, the figures were 12.25% for the fund and 9.84% for the benchmark.
For the quarter ended September 30, 2026, the fund returned -2.86%, while the benchmark returned -7.23%. The fund’s year-to-date return was 22.21%, compared with 13.71% for the index. Returns for periods under one year are cumulative; other figures are average annual returns. The fact sheet states that performance includes reinvested dividends and capital gains distributions and is net of expenses.
Calendar-year results show that relative performance has varied. In 2022, the fund returned -32.37%, compared with -20.44% for the benchmark. In 2020, the fund returned 49.26%, while the index returned 19.96%. These examples underscore that results can differ substantially from the benchmark in individual years. Past performance does not guarantee future results, and current performance may be higher or lower than the figures shown.
Sector allocation and largest holdings
As of the fact sheet date, healthcare represented 34.5% of sector diversification and technology represented 24.1%. Other reported allocations included energy at 10.8%, industrials at 10.7%, consumer cyclical at 6.3%, financial services at 4.7%, consumer defensive at 3.2%, communication services at 3.1%, basic materials at 2.0%, and utilities at 0.7%. Real estate was reported at 0.0%.
The ten largest holdings accounted for 26.2% of total net assets. Listed companies included Flotek Industries, Impinj, CareDx, Magnite, Strata Critical Medical, Definium Therapeutics, PaySign, Hinge Health, Axsome Therapeutics, and Xeris Biopharma Holdings. Holdings and allocations describe the portfolio at a point in time and can change.
Expenses and fund details
The Service Class ticker is RYVPX. The fund’s inception date is June 14, 2001, and its reported turnover rate is 75.0%. Total net assets were $125 million as of September 30, 2026. The gross expense ratio was 1.57%, while the net expense ratio was 1.49% as of May 1, 2026. The fact sheet says a fee waiver was in effect through April 30, 2027. It also notes that an additional recordkeeping or administrative fee may apply to participants investing plan assets in the fund.
Risks to consider
Small-cap stocks may underperform larger companies or the broader market. Smaller, less-seasoned businesses may also face greater liquidity risk and price volatility, including because of limited product lines, management experience, market share, or financial resources. More generally, equity values can fall due to changes in an issuer’s financial condition or broader market and economic conditions.
The fund’s growth orientation creates additional sensitivity to earnings expectations and market fluctuations. Its sector allocations also matter: the fact sheet identifies technology-sector concentration as a potential source of risk, including exposure to competitive pressures, short product cycles, intellectual property dependence, and legislative or regulatory changes. Investors can lose some or all of their principal, and investment value is not guaranteed or insured by a U.S. government agency.
What investors should take away
The Royce Small-Cap Growth Fund offers a defined small-company growth strategy, with substantial reported exposure to healthcare and technology and performance that has varied against the Russell 2000 across different periods. When assessing it, investors should consider both its long-term objective and the possibility of sharp declines, its expenses and any plan-level fees, and whether its portfolio risks fit their circumstances. The fact sheet directs investors to review the prospectus for the fund’s objectives, risks, charges, and expenses before investing.